{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:41:06Z","timestamp":1780648866171,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.urolonc.2024.07.009","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:09:04Z","timestamp":1724371744000},"page":"449.e21-449.e28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical performance of Bladder EpiCheck\u2122 versus voided urine cytology for detecting recurrence of nonmuscle invasive bladder cancer: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"42","author":[{"given":"Cho-Han","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Syuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aunchalee","family":"Jaroenlapnopparat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff Chun Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Liang","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui-Un","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8759-3093","authenticated-orcid":false,"given":"Yuan Ping","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hsien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2024.07.009_bib0001","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.009_bib0002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0970-1591.166445","article-title":"Non-muscle invasive bladder cancer risk stratification","volume":"31","author":"Isharwal","year":"2015","journal-title":"Indian J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.009_bib0004","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.009_bib0005","first-page":"474","article-title":"Adverse effects of cystoscopy and its impact on patients' quality of life and sexual performance","volume":"6","author":"Stav","year":"2004","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.009_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.11.001","article-title":"Diagnostic performance of the bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: a single centre, prospective, blinded clinical trial","volume":"40","author":"Cochetti","year":"2022","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.07.009_bib0009","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.009_bib0010","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.clgc.2022.03.009","article-title":"The role of bladder epicheck test in follow-up of patients with non-muscle invasive bladder cancer","volume":"20","author":"Ragonese","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.009_bib0011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.009_bib0012","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.009_bib0013","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.009_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-14-70","article-title":"Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study","volume":"14","author":"van Enst","year":"2014","journal-title":"BMC Med Res Method"},{"issue":"6","key":"10.1016\/j.urolonc.2024.07.009_bib0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14673","article-title":"Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer","volume":"123","author":"D'Andrea","year":"2019","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.009_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.22246","article-title":"Comparison of 2 new real-time polymerase chain reaction\u2013based urinary markers in the follow-up of patients with non\u2013muscle-invasive bladder cancer","volume":"128","author":"Trenti","year":"2020","journal-title":"Cancer Cytopathology"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.11.013","article-title":"The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma","volume":"40","author":"Pierconti","year":"2022","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.009_bib0018","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.acuro.2023.05.007","article-title":"Bladder Epicheck\u00ae for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience and follow-up proposal","volume":"47","author":"Ca\u00f1o Velasco","year":"2023","journal-title":"Actas Urol Esp (Engl Ed)"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.009_bib0019","first-page":"384","article-title":"Performance characteristics of urinary cytology in patients presenting with gross and microscopic hematuria","volume":"9","author":"Pan","year":"2021","journal-title":"Am J Clin Exp Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.009_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0021","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bju.13760","article-title":"Guideline of guidelines: non-muscle-invasive bladder cancer","volume":"119","author":"Woldu","year":"2017","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0022","first-page":"651","article-title":"The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer","volume":"32","author":"Karaoglu","year":"2014","journal-title":"World J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2024.07.009_bib0023","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.urolonc.2016.05.028","article-title":"Follow-up in non-muscle-invasive bladder cancer-international bladder cancer network recommendations","volume":"34","author":"Kassouf","year":"2016","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.009_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"issue":"18","key":"10.1016\/j.urolonc.2024.07.009_bib0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.009_bib0026","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J Urol"},{"issue":"15_suppl","key":"10.1016\/j.urolonc.2024.07.009_bib0027","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1200\/JCO.2020.38.15_suppl.5026","article-title":"Clinical outcomes and economic burden for bladder cancer patients: an analysis from a Swedish cancer registry","volume":"38","author":"Bellmunt","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.009_bib0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/diagnostics10010039","article-title":"Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review","volume":"10","author":"Batista","year":"2020","journal-title":"Diagnostics (Basel)."}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:33:43Z","timestamp":1731746023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924005489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1078143924005489"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical performance of Bladder EpiCheck\u2122 versus voided urine cytology for detecting recurrence of nonmuscle invasive bladder cancer: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}